437 related articles for article (PubMed ID: 3050278)
1. Differential inhibition of estrogen and antiestrogen binding to the estrogen receptor by diethylpyrocarbonate.
Borgna JL; Scali J
J Steroid Biochem; 1988 Oct; 31(4A):427-36. PubMed ID: 3050278
[TBL] [Abstract][Full Text] [Related]
2. Differential interactions of estrogens and antiestrogens at the 17 beta-hydroxy or counterpart function with the estrogen receptor.
Borgna JL; Scali J
Eur J Biochem; 1991 Aug; 199(3):575-85. PubMed ID: 1868844
[TBL] [Abstract][Full Text] [Related]
3. Diethylpyrocarbonate inhibition of estradiol receptor binding to oligonucleotides.
Gross SC; Kumar SA; Dickerman HW
Mol Cell Endocrinol; 1981 Jun; 22(3):371-84. PubMed ID: 7250488
[TBL] [Abstract][Full Text] [Related]
4. Differential interactions of estrogens and antiestrogens at the 17 beta-hydroxyl or counterpart hydroxyl with histidine 524 of the human estrogen receptor alpha.
Aliau S; Mattras H; Richard E; Bonnafous JC; Borgna JL
Biochemistry; 2002 Jun; 41(25):7979-88. PubMed ID: 12069588
[TBL] [Abstract][Full Text] [Related]
5. Diethyl pyrocarbonate, a histidine selective reagent, inhibits estrogen binding to receptor protein in rat uterus cytosol.
Baker ME; Sklar DH; Terry LS; Hedges MR
Biochem Int; 1985 Aug; 11(2):233-8. PubMed ID: 4052089
[TBL] [Abstract][Full Text] [Related]
6. Extensive in situ activation of nuclear estrogen receptors after exposure of murine uteri to [3H]estradiol or [3H]4-hydroxytamoxifen.
Pavlik EJ; Nelson K; van Nagell JR; Donaldson ES; Walden ML; Gallion H; Kenady DE
Endocrinology; 1987 Apr; 120(4):1608-14. PubMed ID: 3830064
[TBL] [Abstract][Full Text] [Related]
7. Interaction of the antiestrogen [3H]H1285 with the two forms of the molybdate-stabilized calf uterine estrogen receptor.
Keene JL; Ruh MF; Ruh TS
J Steroid Biochem; 1984 Dec; 21(6):625-31. PubMed ID: 6527530
[TBL] [Abstract][Full Text] [Related]
8. Antiestrogen pharmacology and mechanism of action.
Katzenellenbogen BS; Miller MA; Eckert RL; Sudo K
J Steroid Biochem; 1983 Jul; 19(1A):59-68. PubMed ID: 6887873
[TBL] [Abstract][Full Text] [Related]
9. Physicochemical and genetic evidence for specific antiestrogen binding sites.
Faye JC; Jozan S; Redeuilh G; Baulieu EE; Bayard F
Proc Natl Acad Sci U S A; 1983 Jun; 80(11):3158-62. PubMed ID: 6574477
[TBL] [Abstract][Full Text] [Related]
10. Differences between estrogen- and antiestrogen-estrogen receptor complexes from human breast tumors identified with an antibody raised against the estrogen receptor.
Tate AC; Greene GL; DeSombre ER; Jensen EV; Jordan VC
Cancer Res; 1984 Mar; 44(3):1012-8. PubMed ID: 6692388
[TBL] [Abstract][Full Text] [Related]
11. Human estrogen receptor ligand activity inversion mutants: receptors that interpret antiestrogens as estrogens and estrogens as antiestrogens and discriminate among different antiestrogens.
Montano MM; Ekena K; Krueger KD; Keller AL; Katzenellenbogen BS
Mol Endocrinol; 1996 Mar; 10(3):230-42. PubMed ID: 8833652
[TBL] [Abstract][Full Text] [Related]
12. Cysteine 530 of the human estrogen receptor alpha is the main covalent attachment site of 11beta-(aziridinylalkoxyphenyl)estradiols.
Aliau S; Mattras H; Richard E; Borgna JL
Biochemistry; 1999 Nov; 38(45):14752-62. PubMed ID: 10555957
[TBL] [Abstract][Full Text] [Related]
13. Triphenylethylene antiestrogen-binding sites in cockerel liver nuclei: evidence for an endogenous ligand.
Murphy PR; Butts C; Lazier CB
Endocrinology; 1984 Jul; 115(1):420-6. PubMed ID: 6734522
[TBL] [Abstract][Full Text] [Related]
14. Resistance to tamoxifen with persisting sensitivity to estrogen: possible mediation by excessive antiestrogen binding site activity.
Pavlik EJ; Nelson K; Srinivasan S; Powell DE; Kenady DE; DePriest PD; Gallion HH; van Nagell JR
Cancer Res; 1992 Aug; 52(15):4106-12. PubMed ID: 1638522
[TBL] [Abstract][Full Text] [Related]
15. The dissociation rate of estrogen receptor-ligand complexes is increased by high concentrations of steroids and antiestrogens.
Borgna JL; Ladrech S
Mol Cell Endocrinol; 1982 Jun; 27(1):1-15. PubMed ID: 7106368
[TBL] [Abstract][Full Text] [Related]
16. High-affinity binding of the antiestrogen [3H]tamoxifen to the 8S estradiol receptor.
Capony F; Rochefort H
Mol Cell Endocrinol; 1978; 11(2):181-98. PubMed ID: 680340
[TBL] [Abstract][Full Text] [Related]
17. The effect of free DNA on the interactions of the estrogen receptor bound to hormone, partial antagonist or pure antagonist with target DNA.
Aliau S; Groblewski T; Borgna JL
Eur J Biochem; 1995 Jul; 231(1):204-13. PubMed ID: 7628472
[TBL] [Abstract][Full Text] [Related]
18. Interactions of antiestrogens with human breast cancer in long-term tissue culture.
Lippman M; Bolan G; Huff K
Cancer Treat Rep; 1976 Oct; 60(10):1421-9. PubMed ID: 1035504
[TBL] [Abstract][Full Text] [Related]
19. Diethylpyrocarbonate, a histidine selective reagent, inhibits progestin binding to chick oviduct cytosol.
Baker ME; Terry LS
Steroids; 1983 Dec; 42(6):593-602. PubMed ID: 6687316
[TBL] [Abstract][Full Text] [Related]
20. Estrogen and antiestrogen interaction with estrogen receptor of MCF-7 cells--relationship between processing and estrogenicity.
Gyling M; Leclercq G
J Steroid Biochem; 1988 Jan; 29(1):1-8. PubMed ID: 3347042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
